Three Indians PepsiCo chief Indra Nooyi, ICICI Bank's CEO Chanda Kocchar and Kiran Mazumdar Shaw of Biocon -- have been listed in 'The World's 100 Most Powerful Women' list by Forbes magazine.
'It is not just the US and European opportunity, but it is a huge global opportunity.'
Biocon was scouting for more strategic alliances and exploring opportunities for outlicensing its biotech drugs under development, as it pitches for a slot among the top three bio-pharmaceutical players across the globe, said Kiran Mazumdar-Shaw, chairman and managing director.
The government will investigate every Indian name appearing in an unprecedented leak of financial records, known as the 'Pandora Papers', which alleged that many world leaders have secret offshore stores of wealth.
The Biocon chairman said there is a regulatory path for GM crops which aims to establish safety and efficacy over an accepted period and it has been diligently followed by Bt brinjal on the basis of which the Genetic Engineering Approval Committee has given its positive verdict.
Chaitanya Sagar Bethu (ISB Class of 2010) shares his experience of spending the day with Narayana Murthy, Infosys chief mentor.
Union Finance Minister P Chidambaram regretted that there has been stiff resistance from certain quarters over the reservation bill, which would ensure 33 per cent seats for women in Parliament and legislatures. Chidambaram said this while releasing the book Karmic Divas -- stories of eight powerful and wealthy women written by Prerna Kaul Misra and printed by Vitasta publications.
Researchers and scientists in India would have to be innovative if the country wished to unleash its vast intellectual potential, chairman and managing director of Biocon Ltd Kiran Mazumdar Shaw said on Saturday.
Ajay Lakhotia, an ISB student, shares his experience of spending the day with former managing director and CEO of ICICI Bank KV Kamath and the management lessons that this young MBA grad has learnt from the banking veteran.
The Indian biotech sector continues to face an acute shortage of specialists. But now there is a ray of hope, interestingly from a dark story being narrated in the pharma and biotech sectors in the United States and Europe. The sector is seeing downsizing there. This has made scientists of Indian origin explore opportunities in India. "The shortage and the noticeable gap is in terms of discovery-led drug development," said Kiran Mazumdar Shaw, CMD, Biocon
Nobex, after running out of money last year, had filed for bankruptcy.
As Shah Rukh Khan and Yusuf Arakkal and Rana Dasgupta and Kiran Mazumdar Shaw stand for the best of us, there is too much in daily life that showcases us at our apathetic, or misguided, worst, says Sheba Thayil in this Independence Day column.
In an interview with Nandita Datta she talks about biotechnology becoming the new buzzword and what it takes to build a successful career.
As many as six women, including O P Jindal group chairperson Savitri Jindal and Biocon's Kiran Mazumdar Shaw, have made it to the Forbes' list of 100 richest Indians this year.
Amateur filmmaker Anubhav Srivastava on how his unique film project changed his life.
Mazumdar-Shaw left open whether Biocon will go in for a higher stake or will completely take over the company, which is located near Frankfurt and specialises in manufacturing and marketing a unique range of its own patent-free medicines as well as low-cost drugs from Europan Union nations.
Biocon Ltd ill seek Drug Controller General of India's approval for its novel monoclonal antibody indicated towards the treatment of head and neck cancer, Biomab EGFR.
The company expects insulin, its other branded formulations and research services to drive growth.
Bureaucratic delays are stifling growth in the sector. India should be far more aggressive in launching 'look alike' biological molecules in a fast track manner.
A quiz on women who have made it big in the corporate world.
Three Indian women -- ICICI Bank deputy managing director Chanda Kochhar, HSBC India CEO Naina Lal Kidwai and Biocon head Kiran Mazumdar-Shaw -- have been named among the world's 50 most powerful businesswomen by the Fortune magazine.
New Zealand Prime Minister Helen Clarke on Monday said there were immense opportunities to enhance bilateral trade with India.
On course to become India's first biotech company to be listed on a stock exchange, Bangalore-based Biocon Ltd on Thursday kicked off a roadshow for its initial public offering that opens on March 11.
Indian biotech firm Biocon is developing potential 'blockbuster' drugs for treatment of cancer and diabetes, which could hit the market in two to four years.
Biotechnology major Biocon India Ltd plans to invest over Rs 500 crore on its expansion plans over the next two years.
Biotech major Biocon will file an application with the US Federal Drug Administration to begin clinical trials for oral insulin, which, it says, would be the world's first insulin that could be consumed orally.
India's largest biotech firm Biocon on Wednesday launched its "recombinant human insulin (r-DNA), Insugen
The Karnataka government on Wednesday put the reservation bill for Kannadigas in private firms on hold amid fierce criticism from business leaders and tech tycoons.
"We are growing fast. We are planning to double the manpower to 4,000 from 2,000 at present. Within a very short period we increased the number of employees by 500 to reach 2000," Biocon Chairman and Managing Director Kiran Mazumdar Shaw said.
Arundhati Bhattacharya, the chairperson of country's largest bank SBI, has been named as the most-powerful woman in business in India by Fortune magazine.
Biotech major Biocon, which has projected sales turnover of Rs 700-750 crore (Rs 7-7.5 billion) this year, on Friday said it will launch recombinant human insulin in two weeks.
Biotech firm Biocon India on Friday reported net profits of Rs 138.63 crore (Rs 1.39 billion) for the year 2003-04, a growth of 219 per cent over Rs 43.51 crore (Rs 435.1 million) recorded for the previous fiscal.
These women are building billion-dollar brands, calling the shots in the financial markets, and crisscrossing the globe to broker international agreements and provide aid, the magazine noted
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances